MiNK Therapeutics, Inc.
NASDAQ:INKT
0.7501 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||
| Current Assets: | ||||||||||||||||
| Cash & Cash Equivalents
| 9.314 | 5.817 | 3.367 | 6.399 | 10.622 | 14.892 | 19.636 | 24.159 | 29.847 | 34.688 | 38.889 | 0.819 | 1.658 | -2.691 | 2.691 | -0.299 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.382 | 0 | 0.598 |
| Cash and Short Term Investments
| 9.314 | 5.817 | 3.367 | 6.399 | 10.622 | 14.892 | 19.636 | 24.159 | 29.847 | 34.688 | 38.889 | 0.819 | 1.658 | 2.691 | 2.691 | 0.299 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.023 | 0.035 | 0.063 | 0 | 0.02 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.002 | 2.576 | 2.232 | 0 | 1.031 | 0 |
| Other Current Assets
| 0.16 | 0.182 | 0.231 | 0.029 | 0.166 | 0.321 | 0.47 | 0.038 | 0.378 | 0.605 | 0.721 | 0.011 | 0.248 | 0 | 0.355 | 0 |
| Total Current Assets
| 9.474 | 5.999 | 3.598 | 6.47 | 11.054 | 15.522 | 20.405 | 24.459 | 30.329 | 35.477 | 39.635 | 3.442 | 4.201 | 2.691 | 4.097 | 0.299 |
| Non-Current Assets: | ||||||||||||||||
| Property, Plant & Equipment, Net
| 0.85 | 0.895 | 0.954 | 0.991 | 1.058 | 1.067 | 1.067 | 0.803 | 0.788 | 0.665 | 0.607 | 0.636 | 0.552 | 0 | 0.458 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| -0 | 0 | -0 | 0 | -0 | -0 | -0 | -0 | -0 | 0 | 0 | 0 | 0 | -2.691 | 0 | -0.299 |
| Total Non-Current Assets
| 0.85 | 0.895 | 0.954 | 0.991 | 1.058 | 1.067 | 1.067 | 0.803 | 0.788 | 0.665 | 0.607 | 0.636 | 0.552 | -2.691 | 0.458 | -0.299 |
| Total Assets
| 10.324 | 6.894 | 4.552 | 7.462 | 12.112 | 16.589 | 21.472 | 25.262 | 31.117 | 36.142 | 40.242 | 4.077 | 4.753 | 0 | 4.555 | 0 |
| Liabilities & Equity: | ||||||||||||||||
| Current Liabilities: | ||||||||||||||||
| Account Payables
| 3.202 | 3.487 | 3.912 | 4.281 | 4.886 | 6.002 | 5.823 | 5.172 | 4.791 | 3.727 | 2.996 | 1.648 | 2.268 | 0 | 3.142 | 0 |
| Short Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 65.423 | 52.526 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.324 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.112 | 7.242 | 0 | 0 | 0 |
| Other Current Liabilities
| 6.945 | 7.621 | 7.491 | 6.113 | 6.579 | 5.248 | 6.86 | 13.276 | 12.637 | 15.107 | 13.469 | 5.377 | 5.512 | 0 | 11.08 | 0 |
| Total Current Liabilities
| 10.147 | 11.108 | 11.403 | 10.394 | 11.465 | 11.25 | 12.683 | 18.448 | 17.427 | 18.834 | 16.465 | 80.561 | 67.548 | 0 | 14.222 | 0 |
| Non-Current Liabilities: | ||||||||||||||||
| Long Term Debt
| 4.406 | 4.212 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 43.824 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 12.347 | 11.873 | 11.205 | 10.648 | 10.142 | 9.815 | 9.19 | 0.058 | 4.791 | 3.727 | 2.996 | 0.028 | 0.383 | 0 | 0.383 | 0 |
| Total Non-Current Liabilities
| 16.752 | 16.085 | 11.205 | 10.648 | 10.142 | 9.815 | 9.19 | 0.058 | 4.791 | 3.727 | 2.996 | 0.028 | 0.383 | 0 | 44.207 | 0 |
| Total Liabilities
| 26.9 | 27.193 | 22.608 | 21.042 | 21.607 | 21.065 | 21.873 | 18.506 | 17.427 | 18.834 | 16.465 | 80.589 | 67.931 | 0 | 58.429 | 0 |
| Equity: | ||||||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings
| -139.912 | -137.21 | -133.397 | -127.938 | -122.822 | -116.625 | -110.939 | -103.169 | -96.838 | -90.725 | -82.948 | -77.184 | -62.916 | 0 | -52.735 | 0 |
| Accumulated Other Comprehensive Income/Loss
| -0.611 | -0.386 | -0.431 | -0.313 | -0.402 | -0.374 | -0.292 | -0.078 | 1.297 | -0.102 | -0.625 | -0.789 | -1.335 | -53.874 | -1.523 | -36.334 |
| Other Total Stockholders Equity
| 123.947 | 117.296 | 115.772 | 114.67 | 113.728 | 112.523 | 110.83 | 110.003 | 109.23 | 108.135 | 107.349 | 1.462 | 1.074 | 0 | 0.384 | 0 |
| Total Shareholders Equity
| -16.576 | -20.299 | -18.055 | -13.581 | -9.495 | -4.476 | -0.401 | 6.756 | 13.69 | 17.308 | 23.776 | -76.511 | -63.178 | -53.874 | -53.874 | -36.334 |
| Total Equity
| -16.576 | -20.299 | -18.055 | -13.581 | -9.495 | -4.476 | -0.401 | 6.756 | 13.69 | 17.308 | 23.776 | -76.511 | -63.178 | -53.874 | -53.874 | -36.334 |
| Total Liabilities & Shareholders Equity
| 10.324 | 6.894 | 4.552 | 7.462 | 12.112 | 16.589 | 21.472 | 25.262 | 31.117 | 36.142 | 40.242 | 4.077 | 4.753 | -53.874 | 4.555 | -36.334 |